Class ITerminatedVoluntary: Firm initiated
Ambrosia Brands LLC: food recall H-0546-2026
Ambrosia Brands LLC of New York, NY recalled Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 capsules per bottle; Distributed by: Ambrosia Brands, LLC,… Reason: Product may be contaminated with Salmonella. The FDA listed it as Class I in its Enforcement Report dated Mar 18, 2026; distribution: nationwide.
Record status as published: Terminated (terminated Aug 13, 2026). openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 capsules per bottle; Distributed by: Ambrosia Brands, LLC, 625 Randall Ave, St. 100, Cheyenne, WY 82001; SUGGESTED USE: As a dietary supplement, take two (2) veggie capsules once a day. For best results, take 20-30 min before a meal with an 8oz. glass of water or as directed by your health professional; UPC: 8 60012 16172 0
- Product quantity
- 1,224,208 units
- Reason for recall
- Product may be contaminated with Salmonella
- Codes, lots and dates on the package
- Lot # - Expiration Date: 5020591 - 03/2027 5020592 - 03/2027 5020593 - 03/2027 5020594 - 03/2027 5020595 - 03/2027 5020596 - 03/2027 5030246 - 04/2027 5030247 - 04/2027 5030248 - 04/2027 5030249 - 04/2027 5030250 - 04/2027 5030251 - 04/2027 5040270 - 05/2027 5040271 - 05/2027 5040272 - 05/2027 5040273 - 05/2027 5040274 - 05/2027 5040275 - 05/2027 5040276 - 05/2027 5040277 - 05/2027 5040278 - 05/2027 5040279 - 05/2027 5050053 - 6/2027 5050054 - 6/2027 5050055 - 6/2027 5050056 - 6/2027 5060069 - 07/2027 5060070 - 07/2027 5060071 - 07/2027 5060072 - 07/2027 5060073 - 07/2027 5060074 - 07/2027 5060075 - 07/2027 5060076 - 07/2027 5060077 - 07/2027 5060078 - 07/2027 5060079 - 07/2027 5060080 - 07/2027 5080084 - 9/2027 5080085 - 9/2027 5080086 - 9/2027 5090107 - 10/2027 5090108 - 10/2027 5090109 - 10/2027 5090113 - 10/2027 5090114 - 10/2027 5090115 - 10/2027 5090116 - 10/2027 5090117 - 10/2027 5090118 - 10/2027 5100039 - 11/2027 5100048 - 11/2027
- Distribution pattern
- Nationwide in the United States, including American Samoa, Northern Mariana Islands, Puerto Rico, and Virgin Islands. International distribution to consumers in: Algeria, Anguilla, Australia, Austria, Bahrain, Belgium, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Canada, Chile, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Egypt, Estonia, Faroe Islands, Finland, France, French Polynesia, Georgia, Germany, Gibraltar, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Lithuania, Luxembourg, Malaysia, Malta, Marshall Islands, Mexico, Nauru, New Zealand, Netherlands, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia,…
- Recalling firm
- Ambrosia Brands LLC, New York, NY
- Classification
- Class I — the FDA uses this class for a situation in which there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Press Release
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Feb 13, 2026 |
| Classified by the FDA | Mar 9, 2026 |
| Published in the Enforcement Report | Mar 18, 2026 |
| Terminated | Aug 13, 2026 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0546-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.